, Tracking Stock Market Picks
Enter Symbol:
Abbott Laboratories (ABT) [hlAlert]

up 16.57 %

Abbott Laboratories (ABT) rated Overweight by Morgan Stanley

Posted on: Friday,  Jan 17, 2014  9:25 AM ET by Morgan Stanley

Morgan Stanley rated Overweight Abbott Laboratories (NYSE: ABT) on 01/17/2014. Previously Morgan Stanley rated Overweight Abbott Laboratories (NYSE: ABT) on 01/06/2014.,
when the stock price was $39.15. Since then, Abbott Laboratories has gained 16.58% as of 10/07/2015's recent price of $45.64.
If you would have followed the previous Morgan Stanley's recommendation on ABT, you would have gained 16.57% of your investment in 639 days.

Abbott Laboratories is a global, broad-based health care company devoted to discovering new medicines, new technologies and new ways to manage health. Abbott products span the continuum of care, from nutritional products and laboratory diagnostics through medical devices and pharmaceutical therapies. Abbott comprehensive line of products encircles life itself addressing important health needs from infancy to the golden years.

Morgan Stanley Investment Research is one of the financial industry's dominant thought leaders in equity and fixed-income investing. Our analysts, economists, and strategists have earned this reputation through timely, in-depth analysis of companies, industries, markets, and the world’s economies. Our teams collaborate to assist Morgan Stanley clients with investment decisions, using cash and derivative instruments across major asset classes and geographies.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/17/2014 9:25 AM Buy
as of 10/17/2014
1 Week down  -1.63 %
1 Month down  -5.80 %
3 Months down  -2.48 %
1 YTD up  3.70 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/6/2014 8:25 AM Buy

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy